WHO Pharmaceuticals Newsletter 1999, No. 07&08
(1999; 18 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Close this folderDrug surveillance
View the documentAntidepressants and falls in the elderly: association: Spain
View the documentDrug-induced aplastic anaemia: chloramphenicol eyedrops and nifedipine: Spain
View the documentHerbal medicines regulation: call for public debate: UK
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Open this folder and view contentsMedication errors
Open this folder and view contentsGeneral information
 

Herbal medicines regulation: call for public debate: UK

United Kingdom. The government has called for a wide public debate on the best way to regulate herbal medicines. The Parliamentary Under-Secretary of State for Health (Baroness Hayman) recently met with representatives of the herbal medicines industry and drew attention to the sharp contrast between the rigorous requirements applied licensed pharmaceutical products to demonstrate safety, quality and efficacy and the absence of these requirements for unlicensed products such as herbal medicines.

The current regulatory framework (Medicines Act 1968, Section 12) exempts simple herbal remedies comprising only dried herbs from the licensing requirements applied to medicines, provided that they are sold with no written recommendations for use. Similarly, the licensing requirements do not apply to products sold by herbalists at their own discretion. However, many manufactured herbal remedies are sold from pharmacies and health shops without having been licensed. These products escape the licensing requirements through being considered to be food supplements.

Reference: The Pharmaceutical Journal 262; p.418, 27 March 1999.

 

to previous section to next section
 

Last updated: May 3, 2013